Can-Fite BioPharma Ltd.
CANF
$0.53
-$0.04-6.81%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -43.58% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -43.58% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | -43.58% | |||
| SG&A Expenses | 0.00% | 35.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 16.07% | |||
| Operating Income | 0.00% | -21.36% | |||
| Income Before Tax | 0.00% | -24.29% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -24.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -24.29% | |||
| EBIT | 0.00% | -21.36% | |||
| EBITDA | 0.00% | -20.97% | |||
| EPS Basic | 0.00% | 12.50% | |||
| Normalized Basic EPS | 0.00% | 20.00% | |||
| EPS Diluted | 0.00% | 12.50% | |||
| Normalized Diluted EPS | 0.00% | 20.00% | |||
| Average Basic Shares Outstanding | 0.00% | 34.83% | |||
| Average Diluted Shares Outstanding | 0.00% | 34.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||